CHILDRESS CAPITAL ADVISORS, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1849561
HOUSTON, TX
Position in VRTX
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$311,449
+$39,953 QoQ
Shares Held
627
+3.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,219
of 1,735 holders
Holding Since
Dec 2020
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHILDRESS CAPITAL ADVISORS, LLC holds $906,617 across 3 Biotechnology names. VRTX ranks #2 (34.4% of the industry book) .
All Filings in VRTX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $311,449 | 627 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $271,496 | 608 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $330,952 | 730 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $277,281 | 708 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $338,352 | 760 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $387,856 | 800 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $323,770 | 804 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $357,646 | 769 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $352,946 | 753 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $334,408 | 800 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $353,587 | 869 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $289,667 | 833 | Shares | Sole | 2023-11-06 | |
| 2022-12-31 | $231,024 | 800 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $227,867 | 787 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $221,768 | 787 | Shares | Sole | 2022-08-15 | |
| 2020-12-31 | $74,447 | 315 | Shares | Sole | 2021-03-09 | |
| No filing history on record for this holder in this stock. | ||||||